RESEARCH DIETS

D12266B

特徴

32kcal% 脂肪含有量、バター使用
配合表

脂肪酸組成表
ミネラルミックス組成表
ビタミンミックス組成表

脂肪含有量や脂肪原料、各種原料のご指定などオーダーメイドが可能。
その他の油脂原料を使った飼料はこちら。
配合内容の詳細についてはこちらよりお問合せください。

コントロール飼料

D12489B ： 10kcal% 脂肪含有量
配合表

研究領域 （例）

肥満・糖尿病、 その他

形状

固形・粉末

使用上の注意

固形・粉末 どちらも常温保存可能 ※高温多湿は避けてください※
※粉末飼料の場合、成分の均一さを保つ為飼料交換の都度袋の底から全体を混ぜてください。
→飼料交換回数について　リサーチダイエット社ブログより

対応動物種

マウス　ラット　ハムスター

参考論文・資料

関連論文については、お気軽にこちらよりお申し付けください。

リサーチダイエット社ホームページより

Updated: May 08, 2012

  1. Alberts, P. et al. Selective inhibition of 11ß-hydroxsteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia. 45:1528-1532, 2002.
  2. Alberts, P. et al. Selective inhibition of 11ß-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology. 144:4755-4762, 2003.
  3. Turnbull, A.V., et al. Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats. Diabetes. 51:2441-2449, 2002.
  4. Block, M.H., et al. Discovery and optimization of a series of carbozole ureas as NPY5 antagonists for the treatment of obesity. J. Med. Chem. 45:3509-3523, 2002.
  5. Boustany, C.M., et al. Activation of the systemic and adipose rennin-angiotesin system in rats with diet-induced obesity and hypertension. Am. J. Physiol. Integr. Comp. Physiol. 287: R943-R949, 2004.
  6. Chandler , P.C., et al. Change in CCK-8 response after diet-induced obesity and MC3/4-receptor blockade. Peptides. 25:299-306, 2004.
  7. Chandler , P.C., et al. Feeding response to melanocortin agonist predicts preference for and obesity from a high-fat diet. Physiology and Behavior. 85:221-230, 2005.
  8. Chen, A.S., et al. Role of the melanocortin-4 receptor in metabolic rate and food intake in mice. Transgenic Research. 9:145-154, 2000.
  9. Clegg, D.J., et al. Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet. Am. J. Physiol. 288:981-986, 2005.
  10. DeRuisseuu, L.R., Parsons, A.D., & Overton, J.M. Adaptive thermogenesis is intact in B6 and A/J mice studied at thermoneutrality. Metabolism. 53:1417-1423, 2004.
  11. Bobrian, A.D., et al. Effect of salt on hypertension and oxidative stress in a rat model of diet-induced obesity. Am. J. Physiol. Renal Physiol. 285::F619-F628, 2003.
  12. Dobrian A.D. et al. Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity. Hypertension. 43: 48-56, 2004.
  13. Heinrichs, Stephen. Nonexercise muscle tension and behavioral fidgeting are positively correlated with food availability/palatability and body weight in rats. Physiology & Behavior. 79:199-207, 2003.
  14. Larden, P.J., et al. Differential influence of peroxisome proliferators-activated receptors ? and –a on food intake and energy homeostasis. Diabetes. 52:2249-2259, 2003.
  15. Marsh, D.J., et al. Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. PNAS. 99:3240-3245, 2002.
  16. Shen, C.P., et al. Plasma agouti-related protein level: a possible correlation with fasted and fed states in humans and rats. Journal of Neuroendocrinology. 14:607-610, 2002.
  17. Singh, K.A., et al. Acute insulin-induced elevations of circulating leptin and feeding inhibition in lean but not obese rats. Am. J. Regul. Integr. Comp. Physiol. 289:373-379, 2005.
  18. Singh, D.K., et al. Phosphorylation of supernatant protein factor enhances wits ability to stimulate microsomal squalene monooxygenase. The Journal of Biological achemistry. 278:5646-5651, 2003.
  19. Strack, A.M. et, al. Regulation of body weight and carcass composition by sibutramine in rats. Obesity Research. 10:173-181, 2002.
  20. Warden, C. H., et al. Identification of a congenic mouse line with obesity and body length phenotypes. DOI. 15:460-471, 2004.
  21. Zhou, D., et al. Enhanced running wheel activity of both Mch 1r- and Pmch-deficient mice. Regulatory Peptides. 124:53-63, 2005.
  22. Lauterio TJ, Davies MJ, DeAngelo M, Peyser M, & Lee J. Neuropeptide Y Expression and Endogenous Leptin Concentration in a Dietary Model of Obesity. Obes. Res.. 1999; 7:498-505.
  23. Lauterio TJ, Bond JP, & Ulman EA. Development and characterization of a purified diet to identify obesity-susceptible and resistant rat populations. J. Nutr. 1994; 124:2172-2178.
  24. Lauterio TJ, Barkan A, DeAngelo M, DeMott-Friberg R, & Ramirez R. Plasma growth hormone secretion is impaired in obesity-prone rats before onset of diet-induced obesity. Am. J. Physiol. 1998; 275:E6-11.
  25. Dobrian AD, Davies MJ, Prewitt RL, & Lauterio TJ. Development of hypertension in a rat model of diet-induced obesity. Hypertension. 2000; 35:1009-15.
  26. Dobrian AD, Davies MJ, Schriver SD , Lauterio TJ, & Prewitt RL. Oxidative stress in a rat model of obesity-induced hypertension. Hypertension 2001; 37:554-560.
  27. Levy JR, Lesko J, Krieg RJ, Adler RA & Stevens W. Leptin responses to glucose infusions in obesity-prone rats. Am J Physiol Endocrinol Metab 2000; 279:E1088-1096.
  28. Ghibaudi L, Cook J, Farley C, Van Heek M, & Hwa J. Fat Intake Affects Adiposity, Comorbidity Factors, and Energy Metabolism of Sprague-Dawley Rats. Obes. Res. 10:956-963. 2002
  29. Turnbull A.V., Ellershaw L, Msters D.J., Birtles S, Boyer S, Carroll D, Clarkson P, Loxham S. G. J., McAulay P, Teague J.L., Foote K.M., Pease J. E., & Block M.H. Selective Antagonism of the NPY Y5 Receptor Does Not Have a Major Effect on Feeding in Rats. Diabetes. 51:2441-2449, 2002.
  30. Bouret SG, Gorski JN, Patterson CM, Chen S, Levin BE, Simerly RB. Hypothalamic neural projections are permanently disrupted in diet-induced obese rats. Cell Metab. 2008 Feb;7(2):179-85.
  31. Gorski JN, Dunn-Meynell AA, Levin BE. Maternal obesity increases hypothalamic leptin receptor expression and sensitivity in juvenile obesity-prone rats. Am J Physiol Regul Integr Comp Physiol. 2007 May;292(5):R1782-91. Epub 2007 Jan 11.
  32. Roth JD, Coffey T, Jodka CM, Maier H, Athanacio JR, Mack CM, Weyer C, Parkes DG. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity. Endocrinology. 2007 Dec;148(12):6054-61. Epub 2007 Aug 30.
  33. Shapiro A, Matheny M, Zhang Y, Tümer N, Cheng KY, Rogrigues E, Zolotukhin S, Scarpace PJ. Synergy between leptin therapy and a seemingly negligible amount of voluntary wheel running prevents progression of dietary obesity in leptin-resistant rats. Diabetes. 2008 Mar;57(3):614-22. Epub 2007 Dec 17.
  34. Tizzano JP, Stribling DS, Perez-Tilve D, Strack A, Frassetto A, Chen RZ, Fong TM, Shearman L, Krieter PA, Tschöp MH, Skolnick P, Basile AS. The triple uptake inhibitor (1R,5S)-(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane hydrochloride (DOV 21947) reduces body weight and plasma triglycerides in rodent models of diet-induced obesity. J Pharmacol Exp Ther. 2008 Mar;324(3):1111-26. Epub 2007 Dec 18.
  35. Boustany-Kari CM, Gong M, Akers WS, Guo Z, Cassis LA. Enhanced vascular contractility and diminished coronary artery flow in rats made hypertensive from diet-induced obesity. Int J Obes (Lond). 2007 Nov;31(11):1652-9. Epub 2006 Jul 4.
  36. Cope MB, Jumbo-Lucioni P, Walton RG, Kesterson RA, Allison DB, Nagy TR. No effect of dietary fat on short-term weight gain in mice treated with atypical antipsychotic drugs. Int J Obes (Lond). 2007 Jun;31(6):1014-22. Epub 2007 Jan 16.
  37. Fong TM, Guan XM, Marsh DJ, Shen CP, Stribling DS, Rosko KM, Lao J, Yu H, Feng Y, Xiao JC, Van der Ploeg LH, Goulet MT, Hagmann WK, Lin LS, Lanza TJ Jr, Jewell JP, Liu P, Shah SK, Qi H, Tong X, Wang J, Xu SS, Francis B, Strack AM, MacIntyre DE, Shearman LP. Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents. J Pharmacol Exp Ther. 2007 Jun;321(3):1013-22. Epub 2007 Feb 27.
  38. Guijarro A, Suzuki S, Chen C, Kirchner H, Middleton FA, Nadtochiy S, Brookes PS, Niijima A, Inui A, Meguid MM. Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats. Am J Physiol Regul Integr Comp Physiol. 2007 Oct;293(4):R1474-89. Epub 2007 Jul 11.
  39. Jones HN, Woollett LA, Barbour N, Prasad PD, Powell TL, Jansson T. High-fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57/BL6 mice. FASEB J. 2009 Jan;23(1):271-8. Epub 2008 Sep 30.
  40. Roth JD, Trevaskis JL, Wilson J, Lei C, Athanacio J, Mack C, Kesty NC, Coffey T, Weyer C, Parkes DG. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats. Int J Obes (Lond). 2008 Aug;32(8):1201-10. Epub 2008 Jun 17.

お問合せはこちらまで

▲ページトップへ